معرفی
Brendan Battersby serves as Research Director at the Institute of Biotechnology, University of Helsinki, supervising doctoral candidates in the Doctoral Programme in Biomedicine and Integrative Life Science. His research is conducted from Biocenter 2 at Viikinkaari 5, Helsinki.
Education:
- Ph.D. in Human Genetics, McGill University (2002)
Research Focus: Dr. Battersby investigates mitochondrial protein synthesis quality control, dysfunction mechanisms, and therapeutic interventions for mitochondrial disorders. His work integrates genetics, biochemistry, and molecular biology to address diseases involving mitochondrial translation defects and metabolic dysregulation.
Publication Trends: Recent articles (2023-2025) emphasize mitochondrial dysfunction therapeutics, including Coenzyme Q supplementation, gene replacement strategies, and immunosuppression links in disease models. Key methodologies involve C. elegans systems and human mitochondrial ribosome analysis.
Scientific Recognition:
- No specific awards documented in available records
Grants and Supervision: Leads multiple active projects funded by major institutions:
- Sigrid Jusélius Foundation (€408,422; 2023-2027)
- Finnish Cultural Foundation (€92,000; 2024-2026)
- Magnus Ehrnrooth Foundation (€20,000; 2024-2026)
- Academy of Finland MITOGUARDER project (2024-2027)
Research Infrastructure: Directs mitochondrial biology research within the Institute of Biotechnology and co-organizes international initiatives like the FinMIT Summer School on Organelle Communication.
